Do you want to read an article? Please log in or register.
Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis
Rheumatoid Arthritis
Related content
Rheumatoid Arthritis
Does immunological remission, defined as disappearance of autoantibodies, occur with current treatment strategies? A long-term follow-up study in rheumatoid arthritis patients who achieved sustained DMARD-free status
Ann Rheum Dis.
Boeters DM, Burgers LE, Toes RE, van der Helm-van Mil A
doi: 10.1136/annrheumdis-2018-214868.
Rheumatoid Arthritis
Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial
Ann Rheum Dis.
Kuijper TM, Luime JJ, de Jong PH, Gerards AH, van Zeben D, Tchetverikov I, de Sonnaville PB, van Krugten MV, Grillet BA, Hazes JM, Weel AE
doi: 10.1136/
COMMENTED
Rheumatoid Arthritis
Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort
★ 2
Recommended and commented by
Dr Heino Prillwitz, Faculty Member
Arthritis Res Ther.
Lukas C, Mary J, Debandt M, Daïen C, Morel J, Cantagrel A, Fautrel B, Combe B
doi: 10.1186/s13075-019-2020-x.
Psoriatic Arthritis
Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study
Arthritis Res Ther.
Coates LC, Gladman DD, Nash P, FitzGerald O, Kavanaugh A, Kvien TK, Gossec L, Strand V, Rasouliyan L, Pricop L, Ding K, Jugl SM, Gaillez C; FUTURE 2 study group
doi: 10.1186/s13075-018-1773-y.
Rheumatoid Arthritis
Therapeutic strategy for Rheumatoid Arthritis Patients who have achieved Remission
Joint Bone Spine.
Fautrel B
doi: 10.1016/j.jbspin.2018.02.002.
Rheumatoid Arthritis
Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network
Rheumatology (Oxford).
Nikiphorou E, Norton SJ, Carpenter L, Walsh DA, Creamer P, Dixey J, Young A, Kiely PDW
doi: 10.1093/rheumatology/kez461.
Rheumatoid ArthritisSystemic Lupus Erythematosus
Rheumatoid arthritis patients achieved better quality of life than systemic lupus erythematosus patients at sustained remission
Clin Exp Rheumatol.
Pascual-Ramos V, Contreras-Yáñez I, Valencia-Quiñones KR, Romero-Díaz J
Rheumatoid Arthritis
Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study.
Ann Rheum Dis.
Emery P, Bingham CO, Burmester GR, Bykerk VP, Furst DE, Mariette X, van der Heijde D, van Vollenhoven R, Arendt C, Mountian I, Purcaru O, Tatla D, VanLunen B, Weinblatt ME
doi: 10.1136/
Rheumatoid Arthritis
Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial
Ann Rheum Dis.
van Mulligen E, Weel AE, Hazes JM, van der Helm-van Mil A, de Jong PHP
doi: 10.1136/annrheumdis-2020-217485.